Multisystem inflammatory syndrome in children and adults is a rare but serious illness that can happen after COVID-19. It causes widespread inflammation and often brings fever, severe stomach pain, vomiting, diarrhea, rash, red eyes, dizziness, or trouble breathing. Not everyone will have the same experience. Multisystem inflammatory syndrome in children and adults usually develops days to weeks after the infection, and many people need hospital care, but most improve with prompt treatment such as fluids, steroids, and other medicines that calm the immune system. Death can happen in severe cases, especially when the heart or other organs are affected, so early symptoms of multisystem inflammatory syndrome in children and adults need urgent medical attention.
How many people live with Multisystem inflammatory syndrome in children and adults?
Worldwide, there is no single authoritative total for this rare inflammation problem linked to COVID-19, because countries often count children and adults separately and do not report cases in the same way. In the United States, more than 9,000 children have been reported with the child form, MIS-C (CDC, 2024), while the adult form, MIS-A, is much rarer and does not have one routinely updated national total.
Overview
Multisystem inflammatory syndrome in children and adultsSymptoms
Multisystem inflammatory syndrome in children and adults often causes ongoing fever, rash, red eyes, vomiting, diarrhea, belly pain, and unusual tiredness. Some also develop dizziness, trouble breathing, chest pain, or confusion, which can mean the heart or other organs are affected.
Outlook and prognosis
With prompt treatment, most people with multisystem inflammatory syndrome in children and adults recover well, often within days to weeks. Outlook depends on how strongly the heart and other organs were affected, so close follow-up is important after leaving the hospital.
Causes and risk factors
Multisystem inflammatory syndrome in children and adults usually follows a recent SARS-CoV-2 infection. Risk appears higher in children and younger adults, and possibly in people with certain genetic or immune differences. Lifestyle factors are not known primary causes.
Genetic influences
Genetics may play a small role in Multisystem inflammatory syndrome in children and adults, likely affecting how strongly the immune system reacts after infection. No single gene is known to cause it, and most risk does not appear to be inherited.
Diagnosis
Doctors diagnose multisystem inflammatory syndrome in children and adults using symptoms, exam findings, blood tests, and signs of recent infection. They also use heart tests, imaging, and other labs to rule out look-alike illnesses.
Treatment and drugs
Treatment for multisystem inflammatory syndrome in children and adults usually starts in the hospital. Doctors often use IV immune therapy, steroids, and supportive care for the heart, breathing, and blood pressure. Some also need blood thinners or other anti-inflammatory medicines.
Symptoms
Someone who was managing school, work, or normal routines can suddenly develop a high fever, bad stomach upset, and marked exhaustion. The early symptoms of multisystem inflammatory syndrome in children and adults can look like a bad viral illness at first, but more signs may appear quickly. Symptoms vary from person to person and can change over time. Chest pain, trouble breathing, confusion, fainting, or being unusually hard to wake are emergency warning signs.
A high fever that lasts or keeps returning is one of the most common symptoms. Many people also look flushed, feel chilled, or seem much less energetic than usual.
Belly pain, vomiting, diarrhea, and poor appetite are very common and can be severe. In some children, the stomach pain is strong enough to make walking upright or eating a normal meal hard.
A rash can appear on different parts of the body, and the eyes may look red without much discharge. Some people also have red or cracked lips, a red tongue, or swelling of the hands and feet.
Fast heartbeat, chest pain, dizziness, or fainting can happen when the heart and blood pressure are affected. Cool, pale skin or unusual sleepiness can be signs that urgent medical care is needed.
How people usually first notice Multisystem inflammatory syndrome in children and adults?
People usually first notice multisystem inflammatory syndrome in children and adults when a high fever does not let up and is joined by symptoms that seem bigger than a routine infection, such as severe stomach pain, vomiting, diarrhea, rash, red eyes, unusual tiredness, or dizziness. In children, parents may first see that their child looks much sicker than expected, is hard to wake, is breathing fast, or seems confused; in adults, many first notice fever along with chest pain, shortness of breath, belly symptoms, or feeling faint. Because these first signs of multisystem inflammatory syndrome in children and adults can worsen quickly, especially after a recent COVID-19 infection, testing positive, or close exposure, it is important to seek urgent medical care if fever is paired with trouble breathing, persistent pain, confusion, blue or pale lips, or signs of dehydration.
Types of Multisystem inflammatory syndrome in children and adults
Multisystem inflammatory syndrome in children and adults can look a little different depending on whether it affects a child or an adult. In practice, the main types of multisystem inflammatory syndrome in children and adults are MIS-C in children and MIS-A in adults, and both usually appear after a recent infection, often after COVID-19. Symptoms don’t always look the same for everyone. Both forms can cause fever and inflammation across several body systems, but the mix of heart, stomach, skin, and breathing symptoms may differ.
MIS-C
This type affects children and teens, and stomach symptoms such as belly pain, vomiting, or diarrhea are often especially prominent. Many children with MIS-C also develop fever, rash, red eyes, tiredness, or signs of heart involvement such as fast heartbeat or low blood pressure. Some may look very unwell quickly, which is why early symptoms of multisystem inflammatory syndrome in children and adults need urgent medical attention when they appear in a child.
MIS-A
This type affects adults, usually after a recent COVID-19 infection, and it often causes fever with chest pain, shortness of breath, severe fatigue, dizziness, or stomach symptoms. Adults with MIS-A may also have heart inflammation, low blood pressure, rash, or red eyes, but some have less obvious lung symptoms than people with a typical acute COVID-19 illness. The balance of symptoms can shift over time.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes like diet, exercise, sleep, or supplements can meaningfully delay the start of multisystem inflammatory syndrome in children or adults. The clearest way to lower the chance of it happening at all, rather than slow its onset, is to reduce the risk of getting COVID-19 and to stay up to date with recommended COVID vaccination, because this rare illness usually appears a few weeks after infection. No step can guarantee prevention, but lowering COVID-19 risk and getting prompt medical care for warning signs may still help people get treated quickly if it does occur.
What genetics can tell you about symptoms
Right now, genetics cannot reliably predict exactly which symptoms someone with multisystem inflammatory syndrome in children or adults will have, how severe those symptoms will be, or when they will start. Early research suggests that inherited differences in immune system genes may affect how strongly the body reacts after a SARS-CoV-2 infection, which could help explain why some people develop more intense inflammation or different organ involvement, but this is still being studied. For now, doctors do not use genetic testing to forecast the symptom pattern of this condition in routine care.
Causes and risk factors
Multisystem inflammatory syndrome in children and adults usually appears 2 to 6 weeks after a COVID-19 infection, even when the earlier illness was mild or unnoticed. The main cause seems to be an immune system overreaction to the virus, and risk is higher when exposure to SARS-CoV-2 is more likely at home, school, work, or in crowded indoor spaces. Children ages 5 to 11 are most often affected by MIS-C, while MIS-A happens in adults after recent infection. Being up to date on COVID-19 vaccination lowers the risk of multisystem inflammatory syndrome after COVID-19 because it helps prevent the triggering infection. No single gene is known to cause multisystem inflammatory syndrome, and researchers are still learning how these pieces fit together.
What are the most common causes or risk factors?
The main known trigger for multisystem inflammatory syndrome in children and adults is a recent COVID-19 infection, usually about 2 to 6 weeks later, even if the earlier illness was mild or caused no symptoms. The clearest risk factors are being in the age groups where it is most often seen, such as children, teens, and younger adults, and not being vaccinated against COVID-19. There is no single proven inherited cause, although researchers think that in some people, passed-down differences in how the immune system reacts may raise the risk.
Environmental and biological risk factors
Multisystem inflammatory syndrome in children and adults is most strongly linked to a recent COVID-19 infection, usually after the infection itself has started to improve. Doctors often group risks into internal (biological) and external (environmental). If you are wondering who is at higher risk for multisystem inflammatory syndrome in children and adults, the main point is that it is uncommon, but risk rises when certain age, immune, and exposure patterns are present.
The clearest risk factor is a recent SARS-CoV-2 infection, even if it was mild or caused no obvious symptoms. Multisystem inflammatory syndrome in children and adults usually appears about 2 to 6 weeks after that infection rather than during the first few sick days.
Places where the virus spreads easily, such as crowded homes, schools, dorms, or public-facing workplaces, raise the chance of catching SARS-CoV-2 in the first place. That matters because without a recent infection, multisystem inflammatory syndrome in children and adults does not develop.
MIS-C is seen most often in school-age children and teenagers, while MIS-A tends to affect younger and middle-aged adults more than older adults. Age seems to influence how the immune system reacts after infection.
Many people with multisystem inflammatory syndrome in children and adults appear to have an unusually strong delayed inflammatory response after the virus has started to clear. Two people with the same exposure can react very differently—biology shapes the response.
Genetic risk factors
For multisystem inflammatory syndrome in children and adults, there is no single inherited cause that explains most cases. The condition seems to happen when the immune system reacts in an unusual, overly strong way after a SARS-CoV-2 infection. Some risk factors are inherited through our genes, but the genetic picture here is still incomplete. Early research suggests that rare immune-related gene changes may raise susceptibility in a small number of people.
No single gene: No one gene is known to cause multisystem inflammatory syndrome in children and adults by itself. In most people, the genetic risk factors for multisystem inflammatory syndrome in children and adults remain unclear.
Immune pathway genes: Early studies suggest that rare changes in genes that help control inflammation or fight viruses may make this syndrome more likely. These findings seem to explain only a small share of cases and are still being confirmed.
Inherited immune disorders: A few children and adults with this syndrome have been found to have previously unrecognized inherited problems with immune function. These are uncommon, but they may help explain why some families have a higher susceptibility.
Family patterns: Family clustering has been reported only rarely, so family history is not a strong or consistent genetic risk factor based on current evidence. People with the same risk factor can have very different experiences.
Lifestyle risk factors
There are no well-established lifestyle habits that directly cause multisystem inflammatory syndrome in children and adults. However, some modifiable factors can affect baseline inflammation, immune function, and the risk of severe acute COVID-19, which may influence how lifestyle affects multisystem inflammatory syndrome in children and adults. Evidence is still limited, so these links are indirect rather than proven causes.
Overweight and obesity are associated with higher background inflammation and a higher risk of severe COVID-19. That may increase vulnerability to a stronger post-infectious inflammatory response, although it is not a proven direct cause of MIS-C or MIS-A.
Low activity levels can worsen cardiometabolic health and may increase the risk of severe illness during acute SARS-CoV-2 infection. In people recovering from infection, poor fitness may also make fatigue, deconditioning, and slower recovery more pronounced if multisystem inflammation develops.
Diets high in ultra-processed foods, added sugars, and excess saturated fat can promote obesity, insulin resistance, and chronic low-grade inflammation. These changes may indirectly worsen the conditions in which an abnormal inflammatory reaction occurs after COVID-19.
Short or irregular sleep can impair immune regulation and raise inflammatory signaling. That may reduce resilience during and after viral infection, even though sleep loss itself is not known to directly trigger MIS-C or MIS-A.
Risk prevention
For most people, the best way to lower the risk of multisystem inflammatory syndrome in children and adults is to prevent the COVID-19 infection that usually comes before it. Staying up to date with COVID-19 vaccines is one of the clearest protective steps, especially for children, and it may also lower risk in adults. Prevention is about lowering risk, not eliminating it completely.
Staying up to date with COVID-19 vaccines lowers the chance of the coronavirus infection that most often triggers multisystem inflammatory syndrome in children and adults. This is one of the most effective answers to how to prevent multisystem inflammatory syndrome in children and adults, especially in children who are eligible for vaccination.
Reducing contact with people who have COVID-19 can lower the chance of the infection that can lead to MIS-C or MIS-A. During high-spread periods, measures like better ventilation, masking in crowded indoor spaces, and staying home when sick can help.
If someone in the home has symptoms or a known exposure, early testing and avoiding close contact can reduce spread to children and other family members. This may lower the risk of the earlier COVID-19 infection that can set off multisystem inflammatory syndrome in children and adults.
Adults at higher risk for severe COVID-19 should ask promptly whether antiviral treatment is appropriate after a positive test. Lowering the severity and duration of infection may also reduce the chance of MIS-A, although prevention data are more limited than they are for vaccination.
Can you prevent Multisystem inflammatory syndrome in children and adults?
There is no sure way to fully prevent multisystem inflammatory syndrome in children or adults, because it appears to be a rare reaction that can happen after a COVID-19 infection. The clearest way to lower the risk is to reduce the chance of getting COVID-19 and to stay up to date on COVID vaccination, since vaccination has been linked to a lower risk of this condition. Even with these steps, prevention is not guaranteed.
Transmission
Multisystem inflammatory syndrome in children and adults, often called MIS-C or MIS-A, is not spread from one person to another. What can spread is the virus that usually comes before it, most often SARS-CoV-2, the virus that causes COVID-19.
For many families wondering how multisystem inflammatory syndrome in children and adults is transferred, the key point is that the syndrome itself is not infectious and usually shows up days to weeks after the earlier infection, when the immune system overreacts. That means being near someone with MIS-C or MIS-A does not give you the condition, but exposure to COVID-19 can raise the risk of developing it later.
When to test your genes
For multisystem inflammatory syndrome in children or adults, routine genetic testing is not recommended for early detection or to guide standard care. Testing may be considered only if the illness is unusually recurrent, severe, or suggests an inherited immune problem, usually with an immunology or genetics specialist.
Diagnosis
Multisystem inflammatory syndrome in children and adults is diagnosed by looking at the whole picture: symptoms, recent infection history, exam findings, and test results. It’s natural to worry when symptoms don’t have a clear explanation. Doctors usually suspect it when fever, rash, stomach pain, trouble breathing, chest pain, or unusual tiredness appear days to weeks after a COVID-19 infection. Because there is no single stand-alone test, the diagnosis of multisystem inflammatory syndrome in children and adults depends on combining several clues while ruling out other causes.
Doctors ask about fever, vomiting, diarrhea, rash, dizziness, breathing problems, and when symptoms started. They also ask about recent COVID-19 infection, exposure, or past positive tests, because timing is an important clue.
The exam checks blood pressure, heart rate, oxygen level, temperature, hydration, and signs of inflammation in the skin, eyes, or mouth. Doctors also look for warning signs such as shock, confusion, or severe belly tenderness that may need urgent treatment.
Blood tests look for inflammation, organ stress, and problems with clotting. These often include markers of inflammation, blood cell counts, kidney and liver tests, and heart-related blood tests to see whether the illness is affecting more than one body system.
Doctors may perform a PCR or rapid test for a current infection and an antibody test for a past infection. This helps connect the illness to SARS-CoV-2, although a negative result does not fully rule it out if the history and other findings fit.
How is Multisystem inflammatory syndrome in children and adults diagnosed?
Multisystem inflammatory syndrome in children and adults is diagnosed in the hospital based on a pattern of findings, not one single test. Doctors look for a recent COVID-19 infection or exposure, a fever, symptoms and signs that more than one body system is affected, and blood tests that show strong inflammation or stress on organs; they may also use heart tests, chest imaging, and urine tests to see which parts of the body are involved. Just as important, they rule out other causes such as serious bacterial infections, and genetic testing is not usually part of making this diagnosis.
Stages of Multisystem inflammatory syndrome in children and adults
Multisystem inflammatory syndrome in children and adults does not have defined progression stages. That is because it is usually an acute illness that appears over days rather than a condition that moves through steady, predictable phases over time. Doctors usually start with a conversation about symptoms such as persistent fever, belly pain, vomiting, rash, chest discomfort, or unusual tiredness, since the early symptoms of multisystem inflammatory syndrome in children and adults can look different from one person to another. Diagnosis and monitoring usually rely on a physical exam, blood tests that show inflammation or strain on organs, and heart checks such as an electrocardiogram or echocardiogram when needed.
Outlook and prognosis
The outlook for multisystem inflammatory syndrome in children and adults is generally good when it is recognized early and treated promptly, with most patients recovering fully after supportive care and immunomodulatory therapy. However, the condition can become life-threatening because of shock, heart dysfunction, abnormal clotting, and failure of multiple organs, so close monitoring is often needed in hospital and sometimes in intensive care. Most children with MIS-C improve within days to weeks, although some need follow-up for lingering fatigue, exercise intolerance, or cardiac findings such as reduced heart function or coronary artery changes. MIS-A in adults also often improves with treatment, but recovery can be more complicated when there are underlying health problems or severe involvement of the heart, kidneys, brain, or lungs. Mortality is uncommon but has been reported in both MIS-C and MIS-A, with death risk highest in patients with delayed diagnosis, severe cardiovascular collapse, or major organ damage. Because long-term outcomes are still being studied, follow-up with cardiology and other specialists is important even after apparent recovery.
Long-term effects
After the early symptoms of multisystem inflammatory syndrome in children and adults have settled, most people improve a lot, but some can have health effects that last for weeks, months, or longer. Multisystem inflammatory syndrome in children and adults most often raises concern about the heart, energy levels, and thinking or mood during recovery. It’s important to remember that long-term doesn’t always mean progressive.
In some people, inflammation can leave temporary or lasting heart changes, such as weaker pumping, abnormal heart rhythms, or changes in the coronary arteries. This is why follow-up visits, blood pressure checks, electrocardiograms, and heart ultrasound scans may continue after the hospital stay.
Many living with multisystem inflammatory syndrome in children and adults feel worn out for a while after the acute illness. Walking to school, climbing stairs, or returning to work may take more effort until strength and exercise tolerance gradually come back.
Some may find that concentration, memory, headaches, or slower thinking linger during recovery. Schoolwork, reading, or multitasking can feel harder than usual, even when the fever and body pain are gone.
A serious illness and hospital treatment can be followed by anxiety, low mood, irritability, or sleep problems. For many, symptoms ease over time, but emotional effects can last longer in some children and adults.
How is it to live with Multisystem inflammatory syndrome in children and adults?
Living with multisystem inflammatory syndrome in children or adults can feel sudden and intense, because a person who seemed to be recovering from a recent infection may quickly become very unwell with fever, severe fatigue, stomach pain, rash, dizziness, or trouble breathing. Daily life often stops for a time, since many people with this condition need urgent medical care, close monitoring, and sometimes a hospital stay, and even after treatment it can take time to rebuild strength and return to school, work, exercise, or usual routines. For families and other close supports, this can be frightening and disruptive too, often bringing worry, missed work or caregiving demands, and the need to help with follow-up visits, medicines, and a gradual return to normal life.
Treatment and drugs
Treatment for multisystem inflammatory syndrome in children and adults usually happens in the hospital because the illness can affect the heart, blood pressure, lungs, kidneys, skin, and digestive system all at once. Doctors often use anti-inflammatory treatment such as intravenous immune globulin, steroids, and sometimes biologic medicines to calm the overactive immune response, while also giving supportive care like IV fluids, oxygen, and medicines to support blood pressure if needed. Because multisystem inflammatory syndrome in children and adults can raise the risk of blood clots, some people also receive blood-thinning medicine, and the care team watches the heart closely with blood tests, heart tracing, and ultrasound scans. Treatment plans often combine several approaches. Most people improve with prompt treatment, but follow-up after leaving the hospital is important, especially if the heart was affected.
Can you cure Multisystem inflammatory syndrome in children and adults?
There is no single cure for multisystem inflammatory syndrome in children and adults, but it can often be treated successfully, especially when care starts quickly. Treatment is usually given in the hospital and may include fluids, medicines that calm the body’s overactive immune response and lower inflammation, and support for the heart, lungs, or other organs if needed. Many people recover well, but follow-up care is important because some may have ongoing heart or other health problems for a while.
Non-drug treatment
Treatment for multisystem inflammatory syndrome in children and adults usually happens in the hospital because symptoms can worsen quickly and more than one organ may be affected at the same time. Beyond prescriptions, supportive therapies can help stabilize breathing, circulation, hydration, and recovery while doctors watch closely for heart and other organ problems. For many families, this can mean a child or adult who seemed to have a fever and stomach pain one day needing careful monitoring the next. Recovery plans vary, but non-drug care often remains important after discharge, especially if there are lingering symptoms or concern about early symptoms of multisystem inflammatory syndrome in children and adults returning.
Close monitoring in the hospital lets the care team track heart rate, blood pressure, oxygen levels, urine output, and other signs that can change fast. This helps doctors respond quickly if multisystem inflammatory syndrome in children and adults starts affecting the heart, lungs, kidneys, or brain.
Some people need extra oxygen through a mask or nasal tube if breathing is hard or oxygen levels drop. In more severe cases, breathing support with a ventilator may be needed while the body recovers.
Careful fluid support can help with dehydration, poor intake, or low blood pressure, but it must be balanced because too much fluid can strain the heart. Nutrition support, including tube feeding in severe illness, may be used if eating and drinking are not enough.
Many living with multisystem inflammatory syndrome in children and adults need heart tests such as echocardiograms and electrocardiograms during recovery. Activity may also be limited for a time if there is heart inflammation or concern about rhythm problems.
Your genes may have an impact on how drugs work for you
For multisystem inflammatory syndrome in children and adults, treatment often includes medicines that calm the immune system and lower inflammation, and people can respond a little differently to these drugs from one person to another. Part of that difference may come from small inherited differences in how the body breaks down medicine or how strongly the immune system reacts, which can affect how well a treatment works or how likely side effects are. Even so, for this condition, doctors usually choose and adjust treatment based on how sick someone is, which organs are affected, and how they improve day by day, rather than using routine genetic testing.
Pharmacological treatments
Treatment for multisystem inflammatory syndrome in children and adults usually happens in the hospital because inflammation can affect the heart, blood vessels, and other organs quickly. Doctors often use medicines that calm the immune system, plus drugs that lower the risk of blood clots or protect the heart while the body recovers. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). The exact plan depends on age, how severe the illness is, and whether someone has signs such as shock, heart weakness, or the early symptoms of multisystem inflammatory syndrome in adults or children.
Intravenous immune globulin, often called IVIG, is one of the main first treatments for MIS-C and is also used in some adults with MIS-A. It is given through a vein and can help settle the overactive immune response and reduce inflammation.
Corticosteroids such as methylprednisolone, prednisolone, or prednisone are commonly used to bring inflammation down more quickly. In more severe multisystem inflammatory syndrome in children and adults, higher doses may be needed at first and then lowered gradually.
Low-dose aspirin is often used when MIS-C affects the heart or blood vessels, especially if there are Kawasaki-like features. It can help lower the risk of clotting, but doctors avoid it in some situations, such as active bleeding or certain low platelet counts.
Anticoagulant drugs such as enoxaparin or heparin may be used when clot risk is high, including with weak heart pumping, very abnormal clotting tests, or large coronary artery changes. These medicines do not treat the inflammation itself, but they can help prevent dangerous blood clots.
Genetic influences
When someone becomes very sick after what seemed like a routine COVID-19 infection, families often want to know why it happened in one child or adult and not another. It’s natural to ask whether family history plays a role. In multisystem inflammatory syndrome in children and adults, often called MIS-C in children and MIS-A in adults, genetics may influence how strongly the immune system reacts after infection, but no single inherited cause explains most cases. Research suggests that some people may carry rare gene changes that affect inflammation or the body’s antiviral defenses, which could raise the risk. Even so, the genetic risk for multisystem inflammatory syndrome in children and adults is still being studied, and most relatives of someone who has had it will not develop the condition. Because MIS-C and MIS-A usually happen after infection rather than being passed down in a simple pattern, genetic testing is not a routine part of care, though specialists may consider it when the illness is unusually severe or there are other clues to an inherited immune problem.
Is Multisystem inflammatory syndrome in children and adults genetic?
Genetics may play a small role in Multisystem inflammatory syndrome in children and adults, likely affecting how strongly the immune system reacts after infection. No single gene is known to cause it, and most risk does not appear to be inherited.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-understood variant in a particular gene may be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When someone is being treated for multisystem inflammatory syndrome in children and adults, the main goal is to bring dangerous inflammation under control quickly and protect the heart and other organs. Researchers are still learning how genetics affect treatment for multisystem inflammatory syndrome in children and adults, and right now genetic testing does not usually decide which medicines are used first. Genetics is only one factor, and doctors usually choose treatments such as immune globulin (IVIG), corticosteroids, and sometimes other immune-calming medicines based on symptoms, lab results, age, body size, and how sick someone is. Rare differences in genes that help control the immune system may partly explain why some people have more intense inflammation or respond differently, but this is not yet precise enough for routine bedside prescribing. In practice, care teams watch closely to see whether fever, heart function, blood pressure, and inflammation markers improve, then adjust treatment if needed. If MIS-C or MIS-A is unusually severe, lasts longer than expected, or happens with a family history of immune problems, doctors may sometimes consider extra genetic evaluation, though this is not standard for most people.
Interactions with other conditions
When multisystem inflammatory syndrome in children and adults happens, the biggest concern is how quickly it can affect organs that may already be under stress from another illness. In practice, it can overlap with infections such as COVID-19, sepsis, or other viral illnesses because the early symptoms of multisystem inflammatory syndrome in children and adults, like fever, rash, stomach pain, and extreme tiredness, can look similar at first. Doctors call it a “comorbidity” when two conditions occur together, and this can make it harder to tell whether symptoms are coming from the inflammatory syndrome itself or from another infection or heart problem. Many living with multisystem inflammatory syndrome in children and adults can also develop inflammation of the heart, blood vessels, kidneys, brain, or digestive system, so existing asthma, diabetes, immune disorders, or chronic heart disease may complicate monitoring and treatment. Some may find that dehydration, low blood pressure, or blood-clotting problems become more serious when another disease is present at the same time. Because multisystem inflammatory syndrome in children and adults can worsen fast, doctors usually watch closely for signs that another illness is contributing and may involve several specialists to guide care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Multisystem inflammatory syndrome in children and adults?
Other illnesses can look a lot like multisystem inflammatory syndrome, especially severe COVID-19 itself, a serious bloodstream infection called sepsis, toxic shock syndrome, and Kawasaki disease in children. These conditions can also cause high fever, rash, red eyes, stomach pain, vomiting, low blood pressure, and heart problems, so doctors often need blood tests, heart checks, and infection testing to tell them apart. If belly pain is the main symptom, problems like appendicitis or a bad stomach or bowel infection may also be considered.
History
When COVID-19 began spreading worldwide, doctors soon noticed that a small number of children became seriously unwell a few weeks after what was often a mild infection. A child who had seemed to be recovering might suddenly develop a high fever, stomach pain, a rash, or extreme tiredness, with inflammation affecting several parts of the body at once. In 2020, researchers and public health teams began describing this pattern in detail, and it became known as multisystem inflammatory syndrome in children, or MIS-C.
As doctors compared cases from different hospitals and countries, it became clear this was not the same as typical acute COVID-19. The timing was a clue: many children tested negative for the virus itself but showed signs of a recent infection, suggesting the illness was linked to the body’s immune response after the infection had passed. Early reports also noted similarities to other inflammatory illnesses seen in childhood, which helped doctors recognize the pattern faster and improve care.
Soon after, similar cases were reported in adults, leading to the term multisystem inflammatory syndrome in adults, or MIS-A. This helped explain why some adults developed fever, heart problems, digestive symptoms, or low blood pressure after recent COVID-19, even if their first infection had not seemed severe. For many living with or recovering from these syndromes, the most important change was that doctors were now looking for them earlier.
The history of multisystem inflammatory syndrome in children and adults is short, but it moved quickly. Health agencies developed case definitions, hospitals shared treatment approaches, and studies helped show that prompt recognition could improve outcomes. That is why awareness of the early symptoms of multisystem inflammatory syndrome remains important today: although these conditions are uncommon, they are now far better understood than they were at the start of the pandemic.